ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,566,000 | -71.2% | 78,200 | -62.8% | 0.01% | -75.0% |
Q2 2018 | $5,429,000 | +2.1% | 210,184 | -5.6% | 0.02% | 0.0% |
Q1 2018 | $5,319,000 | +27.4% | 222,566 | +80.7% | 0.02% | +26.3% |
Q4 2017 | $4,175,000 | +91.1% | 123,200 | +19.4% | 0.02% | +90.0% |
Q3 2017 | $2,185,000 | +21.1% | 103,200 | 0.0% | 0.01% | +11.1% |
Q2 2017 | $1,805,000 | +45.4% | 103,200 | +45.5% | 0.01% | +28.6% |
Q1 2017 | $1,241,000 | +88.3% | 70,928 | +81.9% | 0.01% | +75.0% |
Q4 2016 | $659,000 | +176.9% | 39,000 | +169.0% | 0.00% | +300.0% |
Q3 2016 | $238,000 | – | 14,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |